Journal of Clinical Psychopharmacology

Papers
(The median citation count of Journal of Clinical Psychopharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)49
Risperidone-Associated Stuttering in Patient With Schizophrenia44
Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation39
Blonanserin-Associated Leukopenia38
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset33
Pharmacogenetic Variant Related Higher-Than-Expected Clozapine Concentrations and Clozapine/Norclozapine Ratios in a Patient With Treatment-Resistant Schizoaffective Disorder30
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic27
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents24
Serum Transaminase Monitoring and Successful Treatment of ADHD With Dextroamphetamine in a Patient With Progressive Familial Intrahepatic Cholestasis Type 317
Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome17
Concomitant Use of Clozapine and Suvorexant Doubled Clozapine Plasma Levels: A Case Report17
Question16
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series16
Postinjection Syndrome After Paliperidone?16
Clozapine Use for Bipolar Disorder15
A Study of Cardiac Outcomes After Droperidol Administration in an Inpatient Psychiatric Cohort14
Amisulpride-Associated QTc Prolongation14
Recurrent Clozapine-Associated Pneumonia13
Lethal Suicide Attempt After Dextromethorphan-Associated Sleep Terror13
Notice of Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study13
Question13
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration12
Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment12
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder11
The Yale University Open Data Access Project11
Paliperidone and Edema11
Use of Blonanserin Transdermal Patch in Home Treatment of Schizophrenia10
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes10
Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia10
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress10
Treating Depression Following Biliopancreatic Diversion With Duodenal Switch Surgery10
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder9
Monoamine Oxidase Interactions. Reply to Comments by Drs. Van den Eynde and Gillman9
Subject Index 20239
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”9
The Role of Case Series and Case Reports in Evidence-Based Medicine9
Monoamine Oxidase Inhibitor Interactions8
Methamphetamine-Associated Hyperammonemic Encephalopathy8
Quetiapine in the Anxiety Dimension of Mood Disorders8
Reply: Serotonin Paradox in Burning Mouth Syndrome8
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum8
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics8
Predicting Conversion to Insulin Sensitivity With Metformin8
Donepezil and Inappropriate Sexual Behavior in a Patient With Vascular Dementia and on Bupropion8
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia8
Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression8
Standard Binge Eating Treatments Are Not Effective for My Patient8
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders8
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition8
Safe and Efficacious Use of Duloxetine in a Patient With Congenital Prolonged QT Syndrome7
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates7
Dysphagia to Liquids Only Associated With Olanzapine7
Advancing the Development of New Medications to Treat Psychiatric Illness7
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms7
Can Quetiapine Prolong the Antidepressant Effect of Ketamine?7
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman7
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient7
Ultra-Treatment–Resistant Schizophrenia and Clozapine Augmentation7
How Homogeneous Are Diagnostic Groups?7
Author Index 20227
Trazodone and Mianserin for Delirium6
Mania in a Patient With Pituitrin-Associated Hyponatremia6
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users6
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India6
Recurrent Pancreatitis Associated With Atomoxetine Use in a 9-Year-Old Boy6
The Journal of Clinical Psychopharmacology Consent Policy for Case Reports6
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight6
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia6
Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder5
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases5
The Impact of Serotonin Transporter Binding Affinity on the Risk of Bleeding Related to Antidepressants5
New-Onset Sleepwalking in a Patient Treated With Buspirone5
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report5
Central Nervous System Trial Failures5
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting5
Treating Attention-Deficit/Hyperactivity Disorder in Severe Intellectual Disability with Lisdexamfetamine5
A Seizure After COVID-19 Vaccination in a Patient on Clozapine5
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use5
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation5
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma5
Prevalence and Appropriateness of Antipsychotic Prescribing in an Italian Prison5
Esketamine for Unipolar Major Depression With Psychotic Features5
Subject Index 20245
Effects of Clozapine on Cortical Inhibition5
Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders4
The Modernization of Clozapine4
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment4
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease4
Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up4
Treatment of Clozapine-Associated Sialorrhea4
Pharmacoepidemiology and Clinical Correlates of Lithium Treatment for Bipolar Disorder in Asia4
Cerebellar Cognitive Affective Syndrome and Delusional Disorder Associated With Long-Term Phenytoin Use4
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine4
An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression4
Are the Same Medications that Are Used in the Acute Treatment of Depression the Most Suitable for Preventing Relapse?4
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder4
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia4
Association of Optimal Lamotrigine Serum Levels and Therapeutic Efficacy in Mood Disorders4
Fluoxetine-Associated Enuresis in a Pediatric Patient4
Asthma and Atypical Antipsychotics4
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?4
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients4
Reply to Dr Yucel's Comments on the Article “Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia”4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression4
Further Studies of Effects of Finasteride on Mood and Suicidal Risk4
Alpha Lipoic Acid for Schizophrenia: Future Investigations With Low Doses and Treatment-Resistant Patients—Reply to Letter by Kishi and Colleagues4
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-194
Cervical Dystonia in a Geriatric Patient Associated With Cinacalcet-Clozapine Drug Interaction4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation4
Current Status and Treatment of Rapid Cycling Bipolar Disorder4
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination4
Challenges in the Treatment of Psychotic Bipolar Depression4
Possibly Misleading Pharmaceutical Advertising On TV4
Vortioxetine4
A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder4
Thoughts on the Value of Case Series in the Literature4
Efficacy of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations4
Structured Interventions to Optimize Polypharmacy in Psychiatric Treatment and Nursing Homes4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia4
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?4
Risperidone-Associated Acute Laryngeal Dystonia3
Paroxysmal Perceptual Alterations in Response to Flupentixol3
Adverse Effects After Ayahuasca Administration in the Clinical Setting3
Article Selected to Receive the Mitchell B. Balter Award for 20223
Statistical Versus Clinical Significance3
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning3
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders3
Case Report3
Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials3
Alprazolam3
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder3
Salute to Our Reviewers3
The Need for Non-profit Psychiatric Drug Discovery and Development3
Drug-Associated Liver Injury Related to Antipsychotics3
Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole3
Atomoxetine-Associated Possible Abnormal Uterine Bleeding in an Adolescent3
Augmentation With Pimavanserin in Treatment Refractory Schizophrenia3
Unfair Criticisms of Psychopharmacology3
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia3
Quality Assurance of Depression Ratings in Psychiatric Clinical Trials3
In Memoriam3
Esketamine3
Perphenazine-Associated Nausea3
Albuterol-Associated Hallucinations3
Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation3
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly3
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux3
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine3
Expanding Insights on Clozapine Dosing3
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series3
Characterization of Extended-Release Lorazepam3
The Pitfalls of Psychotropic Polypharmacy3
Treatment of Long-COVID Neuropsychiatric Sequelae Using Tricyclic Antidepressants3
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users3
Treatment History Characteristics Associated With Use of Isocarboxazid3
Time for Rational Pharmacotherapy in Delusional Disorder3
Response to Letter to the Editors From Prof D. Taylor3
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine3
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period2
Risk of Depression Associated With Finasteride Treatment2
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings2
Escitalopram-Associated Tongue Hypoesthesia2
Painful Ejaculation Associated With Atomoxetine and Bupropion2
Melatonin-Responsive Hypnagogic Hallucinations in a Patient With Bipolar Disorder and Posttraumatic Stress Disorder2
Article Selected to Receive the Mitchell B. Balter Award for 20212
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty2
Author Index 20232
Quetiapine in the Treatment of Comorbid Burning Mouth Syndrome and Bipolar II Depression2
Prolonged Paralysis After Electroconvulsive Therapy Due to Butyrylcholinesterase Gene Mutation2
Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder2
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use2
Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder: Erratum2
Can Psychopharmacology Do More for Our Patients With Anosognosia?2
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination2
Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia2
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment During Clozapine Treatment2
Question2
Ketamine for Treatment-Resistant Depression and Suicidality in Adolescents2
Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine2
Clozapine2
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder2
Substance-Related Withdrawal Catatonia in Co-occurring Disorders2
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder2
Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder2
The Placenta and Psychiatry?2
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice2
A Rare Case of Serotonin Syndrome With Buprenorphine and Other Serotonergic Medications2
You Shall Not Turn a Blind Eye to Intraocular Pressure2
Management of Pseudobulbar Affect With Fluoxetine and Dextromethorphan2
Atomoxetine-Associated Maculopapular Rash2
Multiple Medication Use Resulting in Serotonin Syndrome With Deprescribing Resulting in Acute Dystonia2
Erythema Multiforme in a Drug-Naive Patient of Obsessive-Compulsive Disorder Initiated on Fluoxetine2
Olanzapine Reduction From High Dose to Standard Dose2
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy2
Late-Onset Neutropenia With Clozapine Associated With Lithium Carbonate–Related Hyperthyroidism2
Neuroleptic Malignant Syndrome in a 15-Month-Old Child2
Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight2
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism2
Black Hairy Tongue Associated With Olanzapine Use in a Female Dementia Patient2
Methylphenidate-Associated Syncope2
New-Onset Agranulocytosis During Long-term Treatment With Olanzapine2
Rates and Reasons for Clozapine Treatment Interruptions2
Serotonin Paradox in Burning Mouth Syndrome2
Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia2
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression2
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy2
How Patients Describe Their Depressions2
Omicron Variant Infection May Not Exert an Influence on Serum Levels of Clozapine2
Predictors and Correlates of Psychiatric Polypharmacy Among Child and Adolescent Psychiatric Inpatients2
Reply to Comments by Sadko and Jakuszkowiak2
Neurotoxicity Related to Multidrug Association: A Case Report2
Camptocormia Secondary to Antipsychotic-Associated Dystonia of the Rectus Abdominis Muscles Detected by Abdominal Computed Tomography2
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia2
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report2
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus2
Does Bupropion Increase Anxiety?2
Clozapine-Associated Sialorrhea2
Catatonia and Delirium2
Notice of Retraction: Safety and Efficacy of Tramadol in the Treatment of Premature Ejaculation: A Double-blind, Placebo-Controlled, Fixed-Dose, Randomized Study2
Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients2
Aripiprazole for the Treatment of Landolt's Forced Normalization2
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum2
Antidepressant Poisoning Trends in Pediatric Intensive Care2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia2
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)2
Treatment of Refractory Schizophrenia With Clozapine in a Patient With Wolff-Parkinson-White Syndrome1
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium1
The Clinical and Economic Burden of Tardive Dyskinesia in Israel1
Author Index 20211
Bicytopenia in the Context of Olanzapine Treatment1
A Case of a Perinatal Woman on Methadone Maintenance Who Developed Postpartum Torsades de Pointes1
Citalopram and Cannabidiol1
Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics1
Clinical Recommendations for Augmentation Agents in Obsessive-Compulsive Disorder Partially Responsive to Serotonin Reuptake Inhibitors1
Analysis of Duloxetine-Related Adverse Events Using the Food and Drug Administration Adverse Event Reporting System1
A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis1
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports1
Mania With Psychotic Symptoms After Malaria Prophylaxis With Atovaquone-Proguanil1
Aripiprazole as First-Line Therapy for Late-Life Depression1
Surge of Midazolam Use in the Midst of Lorazepam Shortage1
Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms1
Neuroleptic Malignant Syndrome After Lithium Withdrawal1
Vasopressor Requirements in Antipsychotic Overdose1
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning1
Subject Index 20211
Does Concomitant Use of Antidepressants and Direct Oral Anticoagulants Increase the Risk of Bleeding?1
Inverse Association Between Persistence With Antidepressant Medication and Onset of Chronic Pain in Patients With Depression1
A Case of Unexpected Ecchymosis Associated With a High Dose of Venlafaxine1
Physostigmine for Facilitation of Care in Clozapine-Associated Anticholinergic Delirium1
0.31870603561401